← FDA DRUG APPROVALS

FDA ANDA · ANDA202609

AZELASTINE HYDROCHLORIDE

Sponsor: PADAGIS US

APPLICATION
ANDA202609
TYPE
ANDA
ORIGINAL APPROVAL
2017-03-17
LATEST ACTION
2017-03-17
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued

Products

AZELASTINE HYDROCHLORIDEDiscontinued
AZELASTINE HYDROCHLORIDE 0.137MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2017-03-17UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →